In the unadjusted Model 1, a higher ALT/HDL-C ratio was significantly associated with increased odds of NAFLD (OR = 2.833, 95% CI: 2.321–3.456, p < 0.001). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.